American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Cellyan Biotechnology Co., Ltd (HKPD)

$0.37 +10.33% NASDAQ: HKPD · 15-min delayed

Public · NASDAQ: HKPD
27 employees

Visit website Follow

$11.6MMarket cap

27Employees

HKPDNASDAQ

2025IPO

About Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: HKPD
Employees: 27
IPO date: Jan 15, 2025
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: HKPD Nasdaq
SEC CIK: 2007702
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries

Embed this company’s badge

Show Cellyan Biotechnology Co., Ltd’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/cellyan-biotechnology-co-ltd/"><img src="https://americancompanies.com/badge/cellyan-biotechnology-co-ltd.svg" alt="Cellyan Biotechnology Co., Ltd — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Cellyan Biotechnology Co., Ltd and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $11.6M

NASDAQ: HKPD

$0.37 +10.33%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.33 $1.74

52-week range

Market cap: $11.6M
Shares outstanding: 31.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jan 15, 2025

Cellyan Biotechnology Co., Ltd (HKPD) Stock Price

Trading 79% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Cellyan Biotechnology Co., Ltd.

Write a review

Newsroom

News about Cellyan Biotechnology Co., Ltd

Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering Benzinga · 2025-01-16 · positive

News & sentiment via Polygon.io

FAQ

Cellyan Biotechnology Co., Ltd: frequently asked questions

Is Cellyan Biotechnology Co., Ltd an American company?

Cellyan Biotechnology Co., Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Cellyan Biotechnology Co., Ltd publicly traded?

Yes — Cellyan Biotechnology Co., Ltd is a publicly traded company. Its stock trades under the ticker symbol HKPD on the NASDAQ.

What does Cellyan Biotechnology Co., Ltd do?

Cellyan Biotechnology Co., Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

Explore